As in all fields of scientific inquiry, lupus research has been greatly advanced by the caring people who participate in clinical trials. In these studies – usually sponsored by a government organization, a pharmaceutical company or a biotech firm – scientists and participants work together to find safer, more effective methods to diagnose, prevent, treat, and ultimately cure lupus.
Our objective is to get as many qualified people enrolled in lupus clinical trials as possible, to help accelerate the development-to-treatment process. Medicines can affect people differently and must be tested among each potential patient group— by race, gender, age, and ethnic background— so doctors can know how to use them safely and effectively. This is especially important for those that are disproportionately affected by lupus.
For more information about all the lupus clinical trials in the country and the possibility of participating in one, please visit lupustrials.org.